{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:05:12Z","timestamp":1791392712015,"version":"4.3.3"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/mol.112.083758","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T09:39:58Z","timestamp":1355996398000},"page":"759-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":248,"title":["P2X Receptors as Drug Targets"],"prefix":"10.1016","volume":"83","author":[{"given":"R. Alan","family":"North","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.083758_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/ajplegacy.1948.153.3.586","article-title":"A study of the adrenotropic receptors","volume":"153","author":"Ahlquist","year":"1948","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.112.083758_bib2","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1021\/ja00404a040","article-title":"Avermectins: structure determination","volume":"103","author":"Albers-Sch\u00f6nberg","year":"1981","journal-title":"J Am Chem Soc"},{"key":"10.1124\/mol.112.083758_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","article-title":"Guide to receptors and channels (GRAC), 5th edition","volume":"164","author":"Alexander","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib4","doi-asserted-by":"crossref","first-page":"44691","DOI":"10.1074\/jbc.M111.303917","article-title":"The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels","volume":"286","author":"Allsopp","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br Pharmacol Chemother"},{"key":"10.1124\/mol.112.083758_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11375","article-title":"Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes","volume":"489","author":"Baconguis","year":"2012","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1476-5381.2011.01322.x","article-title":"Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2\/3 receptors with in vivo efficacy in a pain model","volume":"163","author":"Ballini","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm1012193","article-title":"Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor","volume":"54","author":"Baqi","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.083758_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1124\/mol.112.083758_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1378\/chest.128.4.1905","article-title":"Effects of aerosolized adenosine 5\u2032-triphosphate vs adenosine 5\u2032-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma","volume":"128","author":"Basoglu","year":"2005","journal-title":"Chest"},{"key":"10.1124\/mol.112.083758_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bjp.0701371","article-title":"Acute nociception mediated by hindpaw P2X receptor activation in the rat","volume":"122","author":"Bland-Ward","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0304-3959(77)90066-5","article-title":"Observations on the algogenic actions of adenosine compounds on the human blister base preparation","volume":"3","author":"Bleehen","year":"1977","journal-title":"Pain"},{"key":"10.1124\/mol.112.083758_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187152708784083821","article-title":"Ionotropic glutamate receptors & CNS disorders","volume":"7","author":"Bowie","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/mol.112.083758_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/371519a0","article-title":"New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor","volume":"371","author":"Brake","year":"1994","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib15","first-page":"716","article-title":"Homomeric and heteromeric P2X3 receptors in peripheral sensory neurons","volume":"9","author":"Brederson","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/mol.112.083758_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.108.141853","article-title":"Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation","volume":"327","author":"Broom","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.083758_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1476-5381.1994.tb16994.x","article-title":"Blockade of P2X-purinoceptors by trypan blue in rat vas deferens","volume":"113","author":"B\u00fcltmann","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.112.083758_bib19","series-title":"Cell membrane receptors for drugs and hormones: A multidisciplinary approach","first-page":"107","article-title":"A basis for distinguishing two types of purnergic receptor","author":"Burnstock","year":"1978"},{"key":"10.1124\/mol.112.083758_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.112.083758_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"Gen Pharmacol"},{"key":"10.1124\/mol.112.083758_bib22","unstructured":"Cantin L, Bayrakdarian M, Buon C, Hu Y, Kennedy V, Laplante M, Leung C, Luo X, Popovic N, Rene O et al. (2010) Pyrrolopyrimidine-based P2X3 antagonists for the treatment of pain. ACS National Meeting, Boston, MA; August 24-26, MEDI-474."},{"key":"10.1124\/mol.112.083758_bib23","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.bmcl.2012.01.124","article-title":"Discovery of P2X3 selective antagonists for the treatment of chronic pain","volume":"22","author":"Cantin","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.083758_bib24","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1523\/JNEUROSCI.4036-07.2007","article-title":"Thr339-to-serine substitution in rat P2X2 receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys308","volume":"27","author":"Cao","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/mol.112.083758_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bmcl.2009.02.003","article-title":"Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)\/P2X(2\/3) antagonist for the treatment of pain","volume":"19","author":"Carter","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.083758_bib26","doi-asserted-by":"crossref","first-page":"ra8","DOI":"10.1126\/scisignal.1162329","article-title":"Regulation of P2X2 receptors by the neuronal calcium sensor VILIP1","volume":"1","author":"Chaumont","year":"2008","journal-title":"Sci Signal"},{"key":"10.1124\/mol.112.083758_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","article-title":"Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain","volume":"114","author":"Chessell","year":"2005","journal-title":"Pain"},{"key":"10.1124\/mol.112.083758_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3565(24)29310-1","article-title":"Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety","volume":"299","author":"Cinkilic","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.083758_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1515\/rns.2011.014","article-title":"Allosteric modulation of ATP-gated P2X receptor channels","volume":"22","author":"Coddou","year":"2011","journal-title":"Rev Neurosci"},{"key":"10.1124\/mol.112.083758_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/371707a0","article-title":"Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans","volume":"371","author":"Cully","year":"1994","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib31","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(98)00316-1","article-title":"NF279: a novel potent and selective antagonist of P2X receptor-mediated responses","volume":"350","author":"Damer","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib32","series-title":"Purinergic signalling in neuron-glia interactions. No. 276","first-page":"253","article-title":"Purinergic signalling between axons and microglia","author":"Di Virgilio","year":"2006"},{"key":"10.1124\/mol.112.083758_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","article-title":"Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states","volume":"151","author":"Donnelly-Roberts","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.106.105890","article-title":"Painful purinergic receptors","volume":"324","author":"Donnelly-Roberts","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.083758_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib36","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1073\/pnas.1119546109","article-title":"Gating mechanism of a P2X4 receptor developed from normal mode analysis and molecular dynamics simulations","volume":"109","author":"Du","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.083758_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1085\/jgp.20028535","article-title":"Control of P2X(2) channel permeability by the cytosolic domain","volume":"120","author":"Eickhorst","year":"2002","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.112.083758_bib38","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1124\/mol.112.083758_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","article-title":"In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization","volume":"8","author":"Ford","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib40","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0701081","article-title":"The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes","volume":"120","author":"Gargett","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","article-title":"Pharmacology of P2X channels","volume":"452","author":"Gever","year":"2006","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.112.083758_bib42","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1476-5381.2010.00796.x","article-title":"AF-353, a novel, potent and orally bioavailable P2X3\/P2X2\/3 receptor antagonist","volume":"160","author":"Gever","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2330309","article-title":"Extracellular ATP: effects, sources and fate","volume":"233","author":"Gordon","year":"1986","journal-title":"Biochem J"},{"key":"10.1124\/mol.112.083758_bib44","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/jm801528x","article-title":"Antagonists of the P2X(7) receptor. From lead identification to drug development","volume":"52","author":"Guile","year":"2009","journal-title":"J Med Chem"},{"issue":"Suppl 1","key":"10.1124\/mol.112.083758_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11302-011-9272-5","article-title":"P2X receptor antagonists for pain management: examination of binding and physicochemical properties","volume":"8","author":"Gum","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11010","article-title":"Molecular mechanism of ATP binding and ion channel activation in P2X receptors","volume":"485","author":"Hattori","year":"2012","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-1838(00)00137-5","article-title":"ATP as a peripheral mediator of pain","volume":"81","author":"Hamilton","year":"2000","journal-title":"J Auton Nerv Syst"},{"key":"10.1124\/mol.112.083758_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.112.081489","article-title":"Salt bridge switching from Arg290\/Glu167 to Arg290\/ATP promotes the closed-to-open transition of the P2X2 receptors","volume":"83","author":"Hausmann","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib49","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1021\/jm300845v","article-title":"N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists","volume":"55","author":"Hernandez-Olmos","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.083758_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-[(cyanoimino)(5-quinolinylamino) methyl]amino-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.083758_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2009.05.018","article-title":"The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice","volume":"204","author":"Honore","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1124\/mol.112.083758_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mol.54.1.22","article-title":"Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues","volume":"54","author":"Humphreys","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib54","doi-asserted-by":"crossref","unstructured":"Hurst R, Rollema H, and Bertrand D (2012) Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther. DOI: 10.1016\/j.pharmthera.2012.08.012","DOI":"10.1016\/j.pharmthera.2012.08.012"},{"key":"10.1124\/mol.112.083758_bib55","doi-asserted-by":"crossref","first-page":"C752","DOI":"10.1152\/ajpcell.00228.2008","article-title":"P2X7 receptor-Pannexin1 complex: pharmacology and signaling","volume":"295","author":"Iglesias","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.112.083758_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2005.07.001","article-title":"The function of microglia through purinergic receptors: neuropathic pain and cytokine release","volume":"109","author":"Inoue","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.112.083758_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11302-007-9071-1","article-title":"Modification of neuropathic pain sensation through microglial ATP receptors","volume":"3","author":"Inoue","year":"2007","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib114","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.drudis.2010.05.011","article-title":"P2Y nucleotide receptors: promise of therapeutic applications","volume":"15","author":"Jacobson","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1124\/mol.112.083758_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/9780470032244.ch6","article-title":"Agonists and antagonists for P2 receptors","volume":"276","author":"Jacobson","year":"2006","journal-title":"Novartis Found Symp"},{"key":"10.1124\/mol.112.083758_bib59","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1021\/jm020046y","article-title":"Purine and pyrimidine (P2) receptors as drug targets","volume":"45","author":"Jacobson","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.083758_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tins.2009.10.003","article-title":"The neural-glial purinergic receptor ensemble in chronic pain states","volume":"33","author":"Jarvis","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.112.083758_bib61","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1073\/pnas.252537299","article-title":"A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2\/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat","volume":"99","author":"Jarvis","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.083758_bib62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuropharm.2008.06.067","article-title":"ATP-gated P2X cation-channels","volume":"56","author":"Jarvis","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.083758_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bjp.0703793","article-title":"Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue","volume":"132","author":"Jarvis","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00424-008-0450-4","article-title":"Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin","volume":"456","author":"Jel\u00ednkova","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.112.083758_bib65","first-page":"82","article-title":"Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors","volume":"58","author":"Jiang","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib66","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/emboj.2012.75","article-title":"Tightening of the ATP-binding sites induces the opening of P2X receptor channels","volume":"31","author":"Jiang","year":"2012","journal-title":"EMBO J"},{"key":"10.1124\/mol.112.083758_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/mol.110.070276","article-title":"Inhibition of neuronal voltage-gated sodium channels by brilliant blue G","volume":"80","author":"Jo","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","article-title":"Molecular and functional properties of P2X receptors\u2014recent progress and persisting challenges","volume":"8","author":"Kaczmarek-H\u00e1jek","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2006.07.034","article-title":"Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs","volume":"547","author":"Kamei","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/mol.53.2.283","article-title":"Ivermectin: a positive allosteric effector of the \u03b17 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Krause","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib71","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature08198","article-title":"Crystal structure of the ATP-gated P2X(4) ion channel in the closed state","volume":"460","author":"Kawate","year":"2009","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib72","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/mol.112.083758_bib73","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/7233","article-title":"Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds","volume":"2","author":"Khakh","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.112.083758_bib74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuron.2012.09.024","article-title":"Neuromodulation by extracellular ATP and P2X receptors in the CNS","volume":"76","author":"Khakh","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/mol.112.083758_bib75","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1523\/JNEUROSCI.19-17-07289.1999","article-title":"Allosteric control of gating and kinetics at P2X(4) receptor channels","volume":"19","author":"Khakh","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/mol.112.083758_bib76","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1093\/emboj\/20.22.6347","article-title":"Proteomic and functional evidence for a P2X7 receptor signalling complex","volume":"20","author":"Kim","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/mol.112.083758_bib77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1476-5381.1994.tb14760.x","article-title":"Inhibition of olfactory cyclic nucleotide-activated current by calmodulin antagonists","volume":"111","author":"Kleene","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib78","first-page":"H1601","article-title":"Calmodulin antagonists depress calcium and potassium currents in ventricular and vascular myocytes","volume":"253","author":"Kl\u00f6ckner","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.112.083758_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(94)90500-2","article-title":"Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones","volume":"259","author":"Kr\u016fsek","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib80","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.4049\/jimmunol.168.12.6436","article-title":"Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response","volume":"168","author":"Labasi","year":"2002","journal-title":"J Immunol"},{"key":"10.1124\/mol.112.083758_bib81","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.bjp.0702001","article-title":"2\u2032,3\u2032-O-(2,4,6- trinitrophenyl) adenosine 5\u2032-triphosphate (TNP-ATP)\u2014a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels","volume":"124","author":"Lewis","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.112.083758_bib82","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1073\/pnas.1118759109","article-title":"Involvement of the cysteine-rich head domain in activation and desensitization of the P2X1 receptor","volume":"109","author":"L\u00f6rinczi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.083758_bib83","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1726-4901(08)70035-2","article-title":"Evaluation of purinergic mechanism for the treatment of voiding dysfunction: a study in conscious spinal cord-injured rats","volume":"70","author":"Lu","year":"2007","journal-title":"J Chin Med Assoc"},{"key":"10.1124\/mol.112.083758_bib84","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1074-7613(01)00229-1","article-title":"Rapid secretion of interleukin-1beta by microvesicle shedding","volume":"15","author":"MacKenzie","year":"2001","journal-title":"Immunity"},{"key":"10.1124\/mol.112.083758_bib85","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1074\/jbc.M507735200","article-title":"Fe65 interacts with P2X2 subunits at excitatory synapses and modulates receptor function","volume":"281","author":"Masin","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib86","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.neuroscience.2007.03.035","article-title":"P2X7-related modulation of pathological nociception in rats","volume":"146","author":"McGaraughty","year":"2007","journal-title":"Neuroscience"},{"key":"10.1124\/mol.112.083758_bib87","doi-asserted-by":"crossref","first-page":"e1002212","DOI":"10.1371\/journal.ppat.1002212","article-title":"The role of the P2X\u2087 receptor in infectious diseases","volume":"7","author":"Miller","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1124\/mol.112.083758_bib115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11302-010-9182-y","article-title":"Emerging structures and ligands for P2X3 and P2X4 receptors-towards novel treatments of neuropathic pain","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib88","doi-asserted-by":"crossref","first-page":"25982","DOI":"10.1074\/jbc.M504545200","article-title":"An intersubunit zinc binding site in rat P2X2 receptors","volume":"280","author":"Nagaya","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1124\/mol.112.083758_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrn2042","article-title":"Ideas about pain, a historical view","volume":"8","author":"Perl","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/mol.112.083758_bib91","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1016\/S0021-9258(17)36591-2","article-title":"Interleukin-1 \u03b2 maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity","volume":"269","author":"Perregaux","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1085\/jgp.200308986","article-title":"Mechanism of ivermectin facilitation of human P2X4 receptor channels","volume":"123","author":"Priel","year":"2004","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.112.083758_bib93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuropharm.2004.11.003","article-title":"Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist","volume":"48","author":"Rettinger","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.083758_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1085\/jgp.200609677","article-title":"Acidic amino acids impart enhanced Ca2+ permeability and flux in two members of the ATP-gated P2X receptor family","volume":"129","author":"Samways","year":"2007","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.112.083758_bib95","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1017550108","article-title":"Preferential use of unobstructed lateral portals as the access route to the pore of human ATP-gated ion channels (P2X receptors)","volume":"108","author":"Samways","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.083758_bib96","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1074\/jbc.M111.322461","article-title":"Allosteric modulation of Ca2+ flux in ligand-gated cation channel (P2X4) by actions on lateral portals","volume":"287","author":"Samways","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuron.2007.03.020","article-title":"Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels","volume":"54","author":"Silberberg","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/mol.112.083758_bib98","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0006-291X(89)92741-1","article-title":"Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells","volume":"165","author":"Soltoff","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.112.083758_bib99","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm.2710","article-title":"Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity","volume":"18","author":"Sorge","year":"2012","journal-title":"Nat Med"},{"key":"10.1124\/mol.112.083758_bib100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"key":"10.1124\/mol.112.083758_bib101","doi-asserted-by":"crossref","first-page":"19526","DOI":"10.1074\/jbc.M701604200","article-title":"A histidine scan to probe the flexibility of the rat P2X2 receptor zinc-binding site","volume":"282","author":"Tittle","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib102","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/B978-0-12-385526-8.00015-1","article-title":"Role of purinergic receptors in CNS function and neuroprotection","volume":"61","author":"Tozaki-Saitoh","year":"2011","journal-title":"Adv Pharmacol"},{"key":"10.1124\/mol.112.083758_bib103","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11302-012-9306-7","article-title":"P2X4 purinoceptor signaling in chronic pain","volume":"8","author":"Trang","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.112.083758_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.resp.2008.11.012","article-title":"Airway nerves and dyspnea associated with inflammatory airway disease","volume":"167","author":"Undem","year":"2009","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1124\/mol.112.083758_bib105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/371516a0","article-title":"A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP","volume":"371","author":"Valera","year":"1994","journal-title":"Nature"},{"key":"10.1124\/mol.112.083758_bib106","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0026-895X(24)13265-8","article-title":"Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2\/3 receptors","volume":"53","author":"Virginio","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.083758_bib107","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(93)81397-I","article-title":"Cloning and functional expression of a brain G-protein-coupled ATP receptor","volume":"324","author":"Webb","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.112.083758_bib108","doi-asserted-by":"crossref","first-page":"15485","DOI":"10.1073\/pnas.93.26.15485","article-title":"Domains of P2X receptors involved in desensitization","volume":"93","author":"Werner","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.083758_bib109","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4155\/fmc.12.4","article-title":"Ion channel drug discovery: challenges and future directions","volume":"4","author":"Wickenden","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1124\/mol.112.083758_bib110","doi-asserted-by":"crossref","first-page":"34017","DOI":"10.1074\/jbc.M205120200","article-title":"Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus","volume":"277","author":"Wilson","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.083758_bib111","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.110.068700","article-title":"Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking","volume":"79","author":"Wolf","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"3, Suppl","key":"10.1124\/mol.112.083758_bib112","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1124\/mol.112.083758_bib113","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.bjp.0700984","article-title":"Vasoconstrictor responses via P2X-receptors are selectively antagonized by NF023 in rabbit isolated aorta and saphenous artery","volume":"120","author":"Ziyal","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.083758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:05:25Z","timestamp":1739963125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24036800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0026895X24036800"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.083758","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X Receptors as Drug Targets","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.083758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}